Clinical Trial Update: PET-Based Imaging of Radiolabeled CIT-013 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating PET-based imaging of radiolabeled CIT-013 for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIT-013

Snippet

Sponsor: Citryll BV | Conditions: RA | Phase 2 | Status: RECRUITING